The company's gross margin declined to 56.9 per cent, down from 60.4 per cent in the corresponding quarter of the previous ...

India Inc’s Q1FY26 profits surge to a four-quarter high even as demand is yet to rebound and revenue growth stays muted.

Pharma major Dr. Reddy's Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1 ...

Persistent Systems reported a 9.8% year-on-year increase in consolidated net profit to ₹4,249.36 million for the quarter ...

The fast-moving consumer goods company of the Tata group — Tata Consumer Products — posted a jump in its topline and bottomline for the first quarter of the financial year 2025-26 (Q1 FY26) post ...

Syngene International reported a 61% increase in consolidated profit after tax, reaching Rs 87 crore in Q1 2025. Revenue rose ...

For the full financial year FY26, Infosys raised its revenue growth guidance to 1–3% in constant currency, narrowing the range from its earlier forecast of 0–3%. The company maintained its operating m ...

Best case scenario, Semaglutide can garner $500 million sales in FY27, HSBC said. It added that Dr Reddy's will be among the ...

Dr Reddys Laboratories reports 2% rise in net profit to Rs 1,418 crore on higher expenses, revenue up 11% Disclaimer: The ...

Persistent Systems' Constant Currency Revenue growth for the quarter stood at 3.3%, which was marginally lower than the 3.8% ...

Coming off a strong end to 2024, Q1 2025 exhibited the seasonal impacts normally expected. Gross collections were down 2.4 ...

The S&P BSE Sensex advanced 539.83 points or 0.66% to 82,726.64. The Nifty 50 index added 159 points or 0.63% to 25,219.90.